The latest portable MRI device has deducted brain abnormalities particularly in 29 out of 30 patients that were taken to Yale New Haven Hospital’s Neuroscience ICU after developing the symptoms of stroke and different neurological disorders, based on a new study published Sept. 8 in the journal JAMA Neurology.
The research is the first identified to attempt to deploy a mobile, bedside, magnetic resonance brain-imaging device, which guarantees to provide an immediate diagnosis to doctors in just about any setting with a regular electrical supply.
“Brain-imaging is must to acute care neurology and is an necessary determinant of proper diagnosis and figuring out the optimum treatment possible,” stated Yale’s Kevin Sheth, professor of neurology and neurosurgery and co-corresponding writer of the new study.
This portable MRI machine is useful to find the evidence of ishcemic stroke, subarchanoid hemorrhage, hemorrhagic stroke, traumatic brain injury, and brain tumors in patients presenting with neurological signs and symptoms at Yale New Haven Hospital.
The Yale group also used the portable MRI device to investigate 20 patients with severe COVID-19 symptoms. Many of those patients have been too sick to be moved to an MRI suite for neurological diagnosis. (Eight had neurological abnormalities).